Taras Shyp

ORCID: 0000-0002-7139-3003
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sarcoma Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • PARP inhibition in cancer therapy
  • Histone Deacetylase Inhibitors Research
  • Lymphoma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • CAR-T cell therapy research
  • Cancer, Hypoxia, and Metabolism
  • Synthesis of Tetrazole Derivatives
  • Synthesis and biological activity
  • Ferrocene Chemistry and Applications
  • Cancer-related molecular mechanisms research
  • Cancer Research and Treatments
  • Economic and Financial Impacts of Cancer
  • Advancements in Semiconductor Devices and Circuit Design
  • Cancer, Lipids, and Metabolism
  • Signaling Pathways in Disease
  • Beetle Biology and Toxicology Studies
  • Low-power high-performance VLSI design
  • RNA modifications and cancer
  • RNA Research and Splicing
  • Radiation Effects in Electronics
  • Cancer Genomics and Diagnostics
  • Diet and metabolism studies
  • Click Chemistry and Applications

BC Cancer Agency
2021-2024

University of British Columbia
2021-2023

Terry Fox Research Institute
2023

Abstract Cancer cells must overcome anoikis (detachment-induced death) to successfully metastasize. Using proteomic screens, we found that distinct oncoproteins upregulate IL1 receptor accessory protein (IL1RAP) suppress anoikis. IL1RAP is directly induced by oncogenic fusions of Ewing sarcoma, a highly metastatic childhood sarcoma. inactivation triggers and impedes dissemination sarcoma cells. Mechanistically, binds the cell-surface system Xc− transporter enhance exogenous cystine uptake,...

10.1158/2159-8290.cd-20-1690 article EN cc-by-nc-nd Cancer Discovery 2021-05-21

Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein expressed in many tissues. High expression levels of ENPP1 have been observed cancer types such as lung cancer, ovarian and breast cancer. Such overexpression has associated with poor prognosis these diseases. Hence, potential target for immunotherapy across multiple cancers. Here, we isolated characterized two high-affinity specific anti-ENPP1 Fab antibody candidates, 17 3G12, from large...

10.3389/fimmu.2023.1070492 article EN cc-by Frontiers in Immunology 2023-01-25

Abstract Purpose: Histone deacetylase (HDAC) inhibition has been shown to induce pharmacologic “BRCAness” in cancer cells with proficient DNA repair activity. This provides a rationale for exploring combination treatments HDAC and PARP types that are insensitive single-agent inhibitors (PARPi). Here, we report the concept characterization of novel bifunctional PARPi (kt-3283) dual activity toward PARP1/2 enzymes Ewing sarcoma cells. Experimental Design: Inhibition was measured using PARP1/2,...

10.1158/1078-0432.ccr-22-3897 article EN cc-by-nc-nd Clinical Cancer Research 2023-06-06

While international consensus and the 2021 WHO classification recognize multiple molecular medulloblastoma subgroups, these are difficult to identify in clinical practice utilizing routine approaches. As a result, biology-driven risk stratification therapy assignment for remains major challenge. Here, we report mass spectrometry-based analysis of samples subgroup discovery, highlighting MYC-driven prognostic signature MYC immunohistochemistry (IHC) as clinically tractable method improved...

10.1093/neuonc/noaf046 article EN PubMed 2025-03-05

Abstract Purpose: Ewing sarcoma is the second most common bone in children, with 1 case per 1.5 million United States. Although survival rate of patients diagnosed localized disease approximately 70%, this decreases to 30% for metastatic and only 10% treatment-refractory disease, which have not changed decades. Therefore, new therapeutic strategies are urgently needed refractory sarcoma. Experimental Design: This study analyzed 19 unique patient- or cell line–derived xenografts (from 14...

10.1158/1078-0432.ccr-23-2187 article EN cc-by-nc-nd Clinical Cancer Research 2023-10-09

Given that ketogenic diets (KDs) are extremely high in dietary fat, we compared different fats KDs to determine which was the best for cancer prevention. Specifically, a Western and 15% carbohydrate diet seven KDs, containing either or enriched medium chain fatty acids (MCTs), milk fat (MF), palm oil (PO), olive (OO), corn (CO) fish (FO) their ability reduce nicotine-derived nitrosamine ketone (NNK)-induced lung mice. While all tested were more effective at reducing nodules than diet, FO-KD...

10.1038/s41598-024-55167-6 article EN cc-by Scientific Reports 2024-03-07

Effective therapies for metastatic osteosarcoma (OS) remain a critical unmet need. Targeting mRNA translation in OS offers promising option, as selective drives the synthesis of cytoprotective proteins under harsh microenvironmental conditions to facilitate competence.

10.1158/1078-0432.ccr-24-1317 article EN cc-by-nc-nd Clinical Cancer Research 2024-07-30

<div>AbstractPurpose:<p>Ewing sarcoma is the second most common bone in children, with 1 case per 1.5 million United States. Although survival rate of patients diagnosed localized disease approximately 70%, this decreases to 30% for metastatic and only 10% treatment-refractory disease, which have not changed decades. Therefore, new therapeutic strategies are urgently needed refractory Ewing sarcoma.</p>Experimental Design:<p>This study analyzed 19 unique patient- or...

10.1158/1078-0432.c.7100006.v1 preprint EN 2024-03-01

Abstract We recently showed that a low-carbohydrate (CHO) diet containing soy protein and fish oil dramatically reduces lung nodules in mouse model of cancer when compared to Western diet. To explore the universality this finding, we herein low-CHO on preventing breast prostate using expresses SV40 large T-antigen specifically epithelia females males. found was significantly reduced with correlated reduction plasma levels glucose, insulin, IL-6, TNFα prostaglandin E2 (PGE2). This also...

10.1093/carcin/bgab106 article EN Carcinogenesis 2021-11-02
Coming Soon ...